Delivery Order SPE2DR25D3301-SPE2DR26F23ZN
Award Date 3/12/26
Potential Completion Date 3/13/26
Potential Value $6.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $5,735.28 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide....
- The Defense Logistics Agency issued a $1,765.38 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for pharmaceutical supply (Barhemsys 5 mg/2 ml vial, 2 ml quantity). The order is issued under the DLA Troop Support Medical IDC, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 ml vials totaling $21,256.63 under a firm fixed price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,078.30 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Barhemsys 5 mg/2 ml vials with a completion date of January 14, 2026. This firm fixed-price contract represents a non-set-aside award issued under open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Barhemsys is a prescription medication used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of BARHEMSYS 10 mg/4 ml vials with a ceiling value of $1,285.79. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries an ultimate completion date...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has a firm fixed price of $1,621.32 and a completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- The Defense Logistics Agency awarded a $2,554.97 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BARHEMSYS (amisulpride) is an atypical antipsychotic medication used in clinical settings to treat...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,390 to Amerisourcebergen Drug Corporation for 4561604815 BARHEMSYS 10 MG/4 ML vials. Under this contract, Amerisourcebergen will deliver 4 ML vials of the drug BARHEMSYS to a location in Conshohocken, Pennsylvania, with performance required by July 27, 2023. The Defense Logistics Agency utilizes such contracts and delivery orders to efficiently procure necessary pharmaceuticals and medical...
- This is a firm-fixed-price delivery order (SPE2DB24D1205|SPE2DB25FCQST) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4566074973 - BARHEMSYS 10 MG/4 ML VIAL 4ML. The $2,676.38 order has an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds indefinite delivery contracts (IDCs) with the DLA and Department of Justice valued up to $999,999,999 and $750,000 respectively for delivering a range of...
- The Defense Logistics Agency Medical Supply Chain issued a $9,474.33 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for pharmaceutical products with an ultimate completion date of March 10, 2026. This is a firm fixed-price delivery order placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order was issued on a non-set-aside, competitive...